As the pharmaceutical industry navigates an era marked by unparalleled change, the 21st Annual Pharmaceutical Compliance Congress (PCC) stands as a critical gathering for professionals in the field of compliance. Known for its tradition of providing educational excellence and ample networking opportunities, the PCC remains a leading forum for addressing pressing compliance challenges and regulatory developments.
Event Overview
This year, the PCC is scheduled for April 16-18, 2024, and will be set against the backdrop of Washington, DC at the Ritz-Carlton, Tysons Corner in McLean, VA. The event promises a comprehensive agenda aimed at enhancing attendees’ understanding of the current compliance landscape and equipping them with forward-looking tools and strategies.
Distinguished Speakers and Sessions
Featuring a roster of esteemed speakers, this year’s PCC includes:
- Neil Falkingham, Senior Vice President, Chief Compliance Officer, GSK, offering insights into global compliance frameworks.
- Betania Glorio, Chief Compliance Officer and Head of Group Compliance and Data Privacy, EMD Serono, focusing on the impact of data privacy on compliance.
- Catherine Gray, PharmD, Acting Director, Office of Prescription Drug Promotion (OPDP), Food and Drug Administration (FDA), discussing guidelines on drug promotion.
- Shefali Kothari, Chief Compliance Officer, IM US, and Country Head, Ethics, Risk, and Compliance, Novartis, exploring the role of ethics in compliance culture.
- Lisa LeCointe-Cephas, Senior Vice President, Chief Ethics and Compliance Officer & Office of General Counsel, Merck, on integrating ethics and compliance in corporate strategies.
- Lucy Muzzy, Vice President & Legal Counsel, Compliance, AI; Digital Health & Medicine; M&A/Business Development, Pfizer, addressing AI and digital health challenges.
- Jacqueline Romero, United States Attorney, US Attorney’s Office for the Eastern District of Pennsylvania, providing enforcement trends and perspectives.
- Steven Benz, Corporate Vice President & General Counsel, Novo Nordisk, looking into the future of compliance and regulatory affairs.
Conference Highlights
Attendees can look forward to:
- Keynotes from leaders at the Centers for Medicare and Medicaid Services (CMS), FDA, Department of Justice (DOJ), Pharmaceutical and Research Manufacturers of America (PhRMA), and more.
- Spotlight on the Department of Health and Human Services Office of Inspector General (HHS OIG) General Compliance Program Guidance update from November 2023.
- Industry-specific updates from the DOJ on enforcement and emerging risks.
- Sessions on critical compliance areas like artificial intelligence (AI), data governance, and social media.
- The Chief Compliance Officer Exchange for sharing best practices.
- Discussions on Diversity, Equity, and Inclusion (DEI) and Environmental, Social, and Governance (ESG) within compliance.
- CLE-accredited content for career advancement.
Innovative Learning Formats
New to 2024, the PCC introduces:
- Tailored event experiences for different expertise levels.
- The PCC Power Hour for case study-driven insights.
- An Innovation Incubator to ignite collaboration and fresh ideas within the industry.
Exclusive Offer for Participants
Policy and Medicine readers are invited to use the promo code PCC24PM for an exclusive 15% discount on registration fees, making this pivotal event more accessible to a wider audience.
*This discount cannot be combined with other offers or applied to existing registrations. Other restrictions may apply.
Join Us at the PCC
The 21st Annual Pharmaceutical Compliance Congress is an indispensable forum for those committed to mastering the complexities of compliance in the pharmaceutical sector. We look forward to welcoming you to The Ritz-Carlton, Tysons Corner in McLean, VA, from April 16-18, 2024, for an event that promises to be both enlightening and inspiring.